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Abstract
Background: India's Revised National Tuberculosis Control Programme (RNTCP) is deemed highly successful in terms 
of detection and cure rates. However, some patients experience delays in accessing diagnosis and treatment. Patients 
falling between the 96th and 100th percentiles for these access indicators are often ignored as atypical 'outliers' when 
assessing programme performance. They may, however, provide clues to understanding why some patients never 
reach the programme. This paper examines the underlying vulnerabilities of patients with extreme values for delays in 
accessing the RNTCP in Mumbai city, India.
Methods: We conducted a cross-sectional study with 266 new sputum positive patients registered with the RNTCP in 
Mumbai. Patients were classified as 'outliers' if patient, provider and system delays were beyond the 95th percentile for 
the respective variable. Case profiles of 'outliers' for patient, provider and system delays were examined and compared 
with the rest of the sample to identify key factors responsible for delays.
Results: Forty-two patients were 'outliers' on one or more of the delay variables. All 'outliers' had a significantly lower 
per capita income than the remaining sample. The lack of economic resources was compounded by social, structural 
and environmental vulnerabilities. Longer patient delays were related to patients' perception of symptoms as non-
serious. Provider delays were incurred as a result of private providers' failure to respond to tuberculosis in a timely 
manner. Diagnostic and treatment delays were minimal, however, analysis of the 'outliers' revealed the importance of 
social support in enabling access to the programme.
Conclusion: A proxy for those who fail to reach the programme, these case profiles highlight unique vulnerabilities 
that need innovative approaches by the RNTCP. The focus on 'outliers' provides a less resource- and time-intensive 
alternative to community-based studies for understanding the barriers to reaching public health programmes.
Background
Mumbai's Revised National Tuberculosis Control Pro-
gramme (RNTCP) is a shining illustration of the Indian
national tuberculosis (TB) control programme, the
world's largest and reportedly highly successful national
TB control programme [1]. In 2008, the Mumbai pro-
gramme enrolled more than 30,000 patients with a case
detection rate of 85% and cure rate of 87% [2]. The
RNTCP uses DOTS, the World Health Organisation's TB
control strategy since 1995 (branded in 2005) that relies
on a standardised regimen administered under direct
observation of patients. For most patients, the time
between onset of symptoms and contact with the first
provider (patient delay) is very short, with a longer time
lag between contact with the first provider and entry into
the programme (provider delay). Once the patients enter
the RNTCP, system delays (diagnostic delay and treat-
ment delay) are minimal. For each of these four indicators
of access to TB care, three to five percent of the patients
experience delays that fall between the 96th and 100th per-
centile values for respective delay variables. For the pur-
pose of this paper, they are referred to as 'outliers',
representing the extreme values that lie beyond what is
considered acceptable for delays in the TB care seeking
process, based on the available literature on delays. They
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are often ignored as rare occurrences or atypical cases
when assessing programme performance.
Far from being atypical, we suggest that these patients
provide us with important clues about why some patients
will never reach the programme. As indicated elsewhere,
patients who do not get on to DOTS form a particularly
vulnerable group with respect to TB control [3,4]. While
successful programmes like the Mumbai RNTCP are
designed and funded to address the health needs of the
poor, economic disadvantage often conflates with other
vulnerabilities that are less easy to recognize and leads to
individuals being 'missed out' by disease control pro-
grammes [5].
Mumbai is the largest metropolis and financial capital
of India and one of the most crowded cities in the world.
Just over half of its inhabitants (54%) reside in slums;
many are migrants drawn to Mumbai by job opportuni-
ties in the city's vast unorganized sector [6,7]. In the
decade between 1991 and 2001, 54.8% of the population
growth in Mumbai was due to in-migration from outside
the state [8]. In these crowded urban environments, indi-
viduals' vulnerability to infectious diseases including TB
is greatly increased [9-12]. TB is the third most common
cause of mortality in Mumbai, accounting for almost one
tenth of the total deaths reported in the city (Personal
communication, Public Health Department of Municipal
Corporation of Greater Mumbai).
While RNTCP services are provided through municipal
(public) and accredited (private) microscopy centres and
DOT (directly observed treatment) centres established
within municipal health care facilities, private providers
are the first point of contact for most TB patients follow-
ing onset of symptoms [13]. Acknowledging the role of
the private sector in TB care, the RNTCP in Mumbai has
formally involved high numbers of private practitioners
(PP) and non-governmental organizations (NGO) that
serve as DOT providers [14]. Patients generally reach the
free TB care services provided through the RNTCP only
after exhausting their resources in the private sector.
This paper draws on a study that explored access of the
urban poor to the RNTCP in Mumbai, India (MAAS-
CHRD, Access to TB care through the RNTCP - Sum-
mary Report, unpublished). Against the background of a
highly successful programme, close attention to the expe-
riences of these patients can elucidate the nature of vul-
nerabilities that underlie delays and missed opportunities
for timely access to effective treatment.
Methods
Study design and sampling
A cross-sectional study was carried out between May
2005 and February 2006. The metropolis of Mumbai is
divided into 24 administrative units called wards with
population of approximately 500,000 each. The sampling
frame for the study component on which this paper is
based was formed by new sputum positive (NSP) patients
registered under the RNTCP at DOT centres in seven of
the 14 slum dominant wards. The first quarter of 2005
was used as the reference period for determining the
sample size. In the selected wards, the DOT centres were
classified into 'low', 'medium', and 'high' based on their
contribution to the ward-level case load. A stratified ran-
dom sampling method was used to select DOT centres
from each ward. All patients from each of the selected
DOT centre who had completed between six and 16
doses were included in the study. The sample thus con-
sisted of 266 NSP patients (15% of the quarterly case
load). All NSP patients registered for treatment in the
three weeks preceding the period of data collection were
included in the sample. Patients less than 15 years of age,
too ill to speak and who were admitted to the hospital
were excluded from the study.
The study was approved by the Institutional Ethics
Committee of the Maharashtra Association of Anthropo-
logical Sciences, Pune, India and the Institutional Review
Board of the London School of Hygiene and Tropical
Medicine, London, UK.
Data collection
After obtaining informed consent, respondents were
interviewed by trained investigators (eight of ten had
post-graduate training in social sciences) using a semi-
structured interview schedule with roughly two-thirds of
the questions framed in an open-ended manner. The
interview schedule elicited information on socio-eco-
nomic background, help-seeking behaviour including
when, why and what type of providers were consulted,
duration of treatment with each provider, investigations
advised, cost of treatment and reason for discontinuing
treatment with each provider, experiences at the micros-
copy and DOT centres, social support received and opin-
ions about direct observation of treatment. We did not,
however, elicit the exact nature of the treatment received
by the patients. The majority of interviews (243/266,
91%) were conducted at the DOT centre. Twenty-three
patients (9%) were interviewed at locations other than the
DOT centre, convenient to the respondent. Privacy was
ensured, wherever possible, by interviewing respondents
in a location where others could not overhear the inter-
view. Respondents unable to speak due to breathlessness
or drowsiness following consumption of medicines were
contacted more than once to complete the interview. All
respondents were interviewed in the intensive phase of
DOTS. Respondent names were kept confidential and
their details were not disclosed to the DOT providers and
the programme managers.
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Data management and analysis
Quantitative data were coded and analysed using SPSS,
Version 10 (SPSS, Chicago Inc, IL, USA). Twenty percent
of all data entry forms were cross-checked for coding and
data entry errors independently by two researchers. 'Out-
liers' were identified from the ranges on patient, provider,
diagnostic and treatment delays. Patient delay was
defined as the period between onset of symptoms and
first contact with a formal health care provider. Provider
delay was defined as the duration between the first con-
tact with the first provider and first visit to the micros-
copy centre. Diagnostic delay was defined as the duration
between the first visit to the microscopy centre and col-
lection of the report. Treatment delay was defined as the
duration between the diagnosis (receipt of reports of spu-
tum examination for acid-fast bacilli (AFB) and the first
dose of the DOTS.
Case profiles were reconstructed from respondents'
open-ended narration of their treatment seeking path-
ways. Respondent names have been changed to maintain
confidentiality; the names used in this paper are pseud-
onyms. Italicised patient quotations are verbatim transla-
tions of open-ended answers provided by respondents.
Results
Cases available for analysis
The valid number of cases available for analysis for each
of the delays is presented in Table 1. For patient and pro-
vider delays, cases in which respondents were unable to
provide details for all help seeking contacts were
excluded. Thirty-eight respondents who underwent spu-
tum examination while admitted to hospitals were
excluded from analysis for diagnostic delay. For treatment
delay, all except four respondents could provide data
regarding duration between diagnosis and, receiving the
first dose of DOTS. Respondents who were beyond the
95th percentile value for the selected four indicators were
listed and compared with the rest of the sample.
Patient profile
Median age for the respondents (n = 266) was 26 years
(range 15 to 80 years, mean = 31 year); more than a third
(99/266, 37%) had up to four years of schooling, less than
half (108/266, 41%) were employed at the time of inter-
view and came from households with a median monthly
per capita income of 778.9 Indian rupees (US$ 17.3). Half
of the respondents (134/266, 50%) had lived in Mumbai
for ten or more years (Table 2).
Forty-one respondents were 'outliers' for one of the
delay variables; only one respondent was an 'outlier' for
two of these variables. The 'outliers' for each of the four
selected delay variables were compared with the rest of
the sample to identify socio-economic variables that
could help predict the 'outliers'.
Patient delay
Two hundred and fifty-five of the 266 (96%) respondents
interviewed for the study could provide valid information
regarding patient delay and were included in the analysis
related to patient delay (Table 1). Half of the respondents
had consulted a first provider within six days of the onset
of symptoms. Eleven percent (27/255) had sought a pro-
vider on the same day as the symptoms started, and more
Table 1: Cases available for analysis
Indicator Patient delay Provider delay Diagnostic delay Treatment delay
Number of respondents 
asked the information
266 266 228 266
Number of respondents 
providing valid responses
255 197 216 262
Minimum - Maximum (days) 0 - 1825 1 - 754 0 - 91 0 - 47
Mean (days) 30 56 5 6
Median (days) 6 27 4 4
95th percentile (days) 92.00 201.20 10.15 22.70
Number of respondents 
beyond 95th percentile (% of 
valid responses)
11 (4%) 9 (5%) 10 (5%) 13 (5%)
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than three-quarters (210/255, 82%) had consulted a pro-
vider within 21 days of onset of symptoms (the cut-off
point for suspicion of TB till revision of diagnostic guide-
lines in 2009). The 95th percentile for the sample con-
sisted of 11 respondents reporting a delay of more than
92 days. These respondents showed wide variation in
most socio-demographic and economic characteristics
such as age, education and employment status. However,
the majority (10/11) had a per capita income of less than
1350 rupees per month (approximately 1 US$ per day) as
compared with the rest of the sample (119/161, 74%)
(Chi-square, p = 0.060). The difference between the outli-
ers and the rest of the respondents was not statistically
significant for any other socio-demographic and eco-
nomic variables.
A patient's subjective evaluation of bodily signs as
symptoms of an illness is the first crucial step - or barrier
- to timely help-seeking. Six of the 11 respondents
reported a gradual onset of symptoms which they did not
"pay attention" to. Others, like 60-year old Baldev Singh
and 45-year old Seetaram, failed to recognise the symp-
toms while under the influence of alcohol. Sixty-seven
year old Babubhai, also on treatment for leprosy, attrib-
uted his cough with expectoration to "many years of
smoking lots of bidis [hand-made local cigarettes]". Fifty-
eight year old Shaikh Ahmed believed that his long term
symptoms of expectoration, fever, and weight loss were
the result of a "chronic cold". The experiences of these
respondents highlight the role of patients' awareness and
perceived gravity of their symptoms as important
prompts in timely help-seeking.
Table 2: Profile of the study sample
Variable Total
Sex n = 266
Female 110 (41%)
Male 156 (59%)
Age (years) n = 266
Mean 31
Median (Range) 26 (15 - 80)
Marital status n = 266
Unmarried 109 (41%)
Married + Others 156 (59%)
Employment status n = 266
Employed 108 (41%)
Unemployed + other 158 (59%)
Monthly per capita income (Rs.) n = 180
Mean 1019.85
Median (Range) 778.89 (37.33 - 4000)
Residence in Mumbai n = 266
Upto 10 years 132(50%)
More than 10 years 134 (50%)
First provider n = 266
Public sector 38 (14%)
Private sector 219 (82%)
Microscopy centre 9 (3%)
Note: Percentages are calculated on valid responses.
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Provider delay
On average, respondents took close to four weeks (n =
197; median 27 days, range: 1 to 754 days) to reach the
microscopy centre following contact with a first provider.
The proportion of women (7/9) and patients with lower
educational status (7/9) was higher among the 'outliers' as
compared with the rest of the sample; women constituted
42% (78/188) and patients with lower educational status
formed 32% (61/188) of the sample. Not only patients'
help-seeking behaviour, but private sector practices con-
tributed to the severe delays incurred by the nine respon-
dents who fell beyond the 95th percentile (201 days). With
respect to consulting health providers, 'outliers' were sim-
ilar to the rest of the sample: the average numbers of pro-
viders contacted and visits paid to these providers did not
differ in the two groups. However, the data from the 'out-
liers' show longer gaps between provider consultations
(Mann-Whitney Test, p = .000), suggesting that 'outliers'
remained with the provider for a longer period than the
rest of the sample. These longer periods of treatment
resulted in costs roughly four times as much as those
incurred by the rest of the sample: median costs for 'outli-
ers' were Rs.1375 (US$ 30.6) versus only Rs.330 (US$ 7.3)
for the rest of the sample (Mann-Whitney Test p = .014).
These costs represent a larger financial burden on the
households of 'outliers' who had lower per capita incomes
than the rest of the individuals in the sample (Mann-
Whitney Test p = .010) (Table 3).
For the outliers, help-seeking in the private medical
sector adversely affected access to TB care. Twenty-year
old Meenadevi was diagnosed and treated for TB for six
months in the private sector. This treatment cost her Rs.
7000 (US$ 155.6), amounting to four times the monthly
per capita income of Rs. 1667 (US$ 37). A month after
completing the six-month course of treatment, her symp-
toms re-appeared. She went to a municipal hospital
where she was diagnosed with TB and started on DOTS.
Meenadevi's story is more or less representative of others
in this group. Eight of the nine 'outliers' consulted a pri-
vate practitioner (PP) before they reached the microscopy
centre. For most of them (6/9), the attending PP either
failed to diagnose TB or did not inform the respondents
of the diagnosis. In the two cases where the attending PP
did diagnose TB, respondents were not referred to the
public sector for TB treatment.
In some cases, however, provider delay was influenced
by respondent behaviour, particularly where respondents
chose to disregard advised regimens for anti-TB treat-
ment. Forty-year old Basappa developed a cough and was
diagnosed with TB and started on anti-TB treatment by a
PP about 15 days later. After two months, Basappa dis-
continued the treatment and went back to his native vil-
lage. Five months later, his symptoms worsened and he
returned to Mumbai and consulted the same PP. Follow-
ing an x-ray, he was re-diagnosed with TB and advised
admission to a hospital. At this point, Basappa chose to
approach the municipal health care facility since he could
not afford in-patient care in the private sector.
Diagnostic delay
Diagnostic delays were on average very short (n = 216;
median 4 days, range 0 to 23). Ten respondents reported
diagnostic delays beyond the 95th percentile (10 days).
This was mainly due to factors beyond the respondents'
control. For 17-year old Fatima, the illness started soon
after she came to Mumbai following her marriage. After
taking "tonics and other medicines" from a number of PPs,
Fatima was advised a chest x-ray by one PP, who diag-
nosed TB and referred her to a municipal centre. The
next day, Fatima went to the centre with her mother-in-
law and gave a sputum sample. On the same day, her
father took her with him to his hometown in an adjoining
district. Fatima returned to the same centre a week later
after her mother-in-law was informed by the health
worker that her sputum sample had tested positive for TB
and that she needed to complete the investigation by pro-
viding two more sputum samples in order to start treat-
ment. Another respondent, 35-year old Kunjappa, a
construction worker, left town on a contract after giving a
single sputum sample. He returned to the microscopy
centre eight days later when a health care provider visited
his house and encouraged him to complete the investiga-
tions. Inability to produce sputum and providing saliva
instead of sputum added to diagnostic delay for 19-year
old Pyarelal and 25-year old Ramesh. The remaining two
respondents experienced delays because of the floods
that brought the city to a standstill in July 2005.
Treatment delay
The average treatment delay was as short as the median
diagnostic delay (n = 262; median 4 days, range 0 to 47
days). Thirteen respondents were beyond the 95th percen-
tile (22 days) for treatment delay. Six of the 13 respon-
dents were diagnosed when admitted to municipal
hospitals and only started on DOTS after being dis-
charged from the hospitals. Delays after discharge from
the hospital were both patient and systems-related. John,
33 years old, could not be registered for DOTS for 15
days, as the health staff at his local DOT centre was occu-
pied with a polio eradication campaign and could not ver-
ify his home address, a pre-condition for entry into the
programme. Meanwhile, John's symptoms worsened and
he needed to be re-admitted to the hospital. John's TB
treatment was finally started 35 days after he was diag-
nosed with TB.
Cultural factors also contributed to delayed initiation of
treatment. Aslam, a 40-year old male who observed the
religious fasts in the Islamic holy month of Ramadaan
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was diagnosed a few days after the holy month began and
chose to wait until the month was over to start the treat-
ment. Similarly, Saraswati, a 52-year old Hindu woman,
went on a pilgrimage before she started the treatment.
Patients who reside in Mumbai for employment pur-
poses tend to be without families and are dependent on
co-workers and acquaintances for shelter. Frequent
changes in residence within the same locality, long work
hours and a reliance on these temporary 'shelters' restrict
these patients' treatment support networks. For example,
despite being resident in Mumbai for six years, 29-year
old Dilip took nearly three weeks to find a person who
could accompany him as guarantor. Twenty-two year old
Pankaj was told that his treatment could start only if he
had a ration card, i.e. proof of residence in the area. As he
did not have one, Pankaj could only start treatment after
the intervention of an NGO social worker, 45 days after
he was diagnosed.
Discussion
Against the backdrop of Mumbai's highly successful TB
control programme, the study focused attention on the
NSP patients who fall outside of the 95th percentile for
delays at each stage of treatment seeking, from onset of
symptoms until initiation of DOTS. For a programme
that enrols more than 30,000 patients per year [2], the
three to five percent 'outliers' for each of the delay indica-
tors amount to a sizeable number. Causes for delays
among TB patients have been explored by a number of
researchers in settings across the world [15-21]. However,
only a few community-based studies have explored the
realities of patients who fail to access treatment through
Table 3: Help-seeking behaviour among 'outliers'
Provider delay
Upto 95th percentile Beyond 95th percentile
Number of providers visited before Microscopy Centre (MC)
n = 188 n = 9
Mean (Range) 2 (1 - 7) 2 (1 - 4)
Number of contacts with providers before MC
n = 188 n = 9
Mean (Range) 4 (1 - 12) 4 (2 - 9)
Duration of treatment before MC (days)
n = 188 n = 9
Median (Range) 11 (1 - 161) 69 (13 - 213)*
*Mann-Whitney Test, p = .000
Period of no-treatment before MC (days)
n = 188 n = 9
Median (Range) 11 (0 - 166) 194 (8 - 736)*
*Mann-Whitney Test, p = .000
Total cost of help-seeking before MC (Rs.)
n = 169 n = 6
Median (Range) 330 (0 - 30735) 1375 (270 - 8500)*
*Mann-Whitney Test, p = .014
Cost of help-seeking before MC as a percentage of PCI (%)
n = 122 n = 4
Median (Range) 34.21 (0 - 10245) 366.67 (80.50 -1455.06)
Mean 176.23 567.22
Note: Percentages are calculated on valid responses.
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the national TB control programmes [22-24]. Identifying
and highlighting the cases of 'outliers', i.e., individuals
who 'just made it' into the programme - as opposed to
discarding them from population based statistical profiles
of a TB control programme - ensures that an analysis of
missed opportunities is comprehensive and grounded in
local level realities [25].
The thread common to all 'outliers' was their poverty:
'outliers' had a significantly lower per capita income than
the rest of the sample. The 'outliers' came from house-
holds with a median per capita income which is below the
poverty line [26]. The cases presented in this paper high-
light the ways in which a lack of economic and material
resources is compounded with social, structural and envi-
ronmental factors, as has been documented by others
[27-29]. Economic poverty translates into particular
social vulnerabilities that impact individual treatment-
seeking pathways. The influence of these vulnerabilities
differs at various stages of the help-seeking process.
Numerous studies have discussed age, gender, access to
financial resources [17,18,20,21,24,30] as well as poor
physical access to diagnostic facilities [19,22] as predic-
tors of higher patient delay. However, for the majority of
respondents in this study, the excellent transport and
public health infrastructure in Mumbai compensated for
most of these barriers. This is seen in the duration of
patient delays which, on average, was shorter than that
reported in other Indian studies [16,17,22] as well as else-
where [18-21]. Rather, it is generalized, chronic illness
conditions that raised the threshold for perceiving a con-
dition of 'serious' morbidity and result in longer patient
delays. The gap between perceived and clinically relevant
symptoms has been well-documented in India [22,24,31]
and South-East Asia [32,33]. Especially among the poor,
acknowledgement of an illness as an abnormal state of
being - and one that deserves care - is a function of
affordability.
This study confirms the importance of the private sec-
tor as a preferred source of TB care [34,35] and the bar-
rier it poses in accessing good quality TB treatment for
some patients [16,22,36]. Provider delays were incurred
as a result of PPs' failure to detect TB, to disclose the
diagnosis to the respondent, and or to refer them to the
public sector when diagnosed. On their own, the respon-
dents turned to public sector facilities only when unable
to afford the costs in the private sector, as documented
elsewhere in India [37]. Surprisingly, awareness about
availability of free TB medicines and history of utilisation
of municipal health services did not encourage respon-
dents to use public sector health services.
Treatment 'shopping' has often been cited as a reason
for higher provider delay [38-40]. However, this study
found that the 'outliers' for provider delay tended not to
'shop', but rather stayed with a provider for longer than
the rest of the sample, and consequently incurred higher
treatment costs. These individuals represent the predica-
ment of those who can barely afford private sector treat-
ment, yet tend to avoid the public sector that might have
provided them with better quality TB care at no cost.
Once patients entered the RNTCP in Mumbai, they
fared on average very well. With the exception of one
case, diagnostic delay in 'outliers' was a result of circum-
stances beyond patients' control. Fatima's story highlights
the situation of most young married women who have
limited access to resources and no say in decision-mak-
ing, even when it concerns their own health. Fatima's
return to the microscopy centre was achieved through
the programme's communication with decision makers
from her family - an essential positive step by the pro-
gramme. Dilip's case illustrates the particular vulnerabil-
ity of urban migrants living in the city without strong
social support networks. An earlier study conducted in
Mumbai showed that one-fifth of the patients who did
not complete the investigations for diagnosis of TB had
left Mumbai to return to their native places [14]. This
contrasts with the results of a study conducted across
four Indian states, in which the main reasons for not
completing the diagnostic procedures were systems-
related [25].
Delays in initiation of treatment, however, can be
equally attributed to systems- and patient-related factors.
Routine administrative procedures involved in registering
the patient for DOTS become obstacles for those who
lack effective treatment support systems [17]. At the
same time, there are a few patients who choose not to ini-
tiate treatment, even when enrolled.
Difficulties faced by the 'outliers' in accessing DOTS
provide an indication of the barriers facing those who fail
to reach the programme. However, our approach relies on
the assumption that 'outliers' and the patients who are
'missed out' by the RNTCP share socio-demographic,
economic and cultural characteristics. We used reported
data from patients to describe all delay variables and
hence did not exclude the period of 21 days (the 'latent'
period that defines a suspect) from the reported care-
seeking pathway. In the case of TB, as with other diseases
that have a gradual onset, patients often find it difficult to
state the exact time of onset of symptoms. Further, clini-
cal practice in a high prevalence population, as that rep-
resented by Mumbai city, varies from the 'ideal'
programmatic and policy scenario. Clinicians do not rely
exclusively on the reported duration of onset of symp-
toms, but often suspect TB based on their experience,
and relevant clinical and social characteristics of the
patient. We also did not collect information on whether
the patient had been in contact with a known case of TB
before being diagnosed with TB. This additional informa-
tion may have partially explained why some patients
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sought treatment within 21 days of onset of treatment, as
contacts of known cases of TB are instructed by health
care providers to report symptoms suggestive of TB
immediately. We were unable to verify reported provider
delays due to lack of documented evidence (e.g. prescrip-
tions, case record sheets etc) of help-seeking in private
clinics.
Notwithstanding these limitations, the profiles of TB
'outliers' provide important clues as to how the pro-
gramme might better reach those patients who are miss-
ing from their statistics. First, there is a need to
strengthen links with private sector providers and
increase their skills to suspect and diagnose TB early. As
strongly suggested in Meenadevi's case, PPs also need to
be convinced of the benefits of referring patients to the
RNTCP early; this has been shown to reduce provider
delays and costs for patients [40]. On the other hand,
migrant patients like Dilip, might benefit from additional
support, through collaborations with community-based
and non-government organisations.
Second, the community needs to be sensitised to the
availability of free TB treatment in the public sector.
Awareness about availability of the services has been
shown elsewhere to influence the patient's choice of a
health provider for TB treatment [32]. In the present
study, past use of public health services did not prompt
current use of the public sector. It is essential to
strengthen the quality of care provided through the pub-
lic sector to ensure greater satisfaction to its users.
Finally, as illustrated in the encouraging cases of Kun-
jappa and Fatima as well as the discouraging cases of
Aslam and Saraswati, health care provider-patient com-
munication can play an important role in shaping
patients' perceptions of the illness, treatment processes
and the quality of health care providers themselves. Both
diagnostic and treatment delay can be addressed by
patient-centred communication, specifically at the time
of the first visit for sputum microscopy and at the time of
disclosing the diagnosis to the patient. The programme
needs to ensure that patients assign due importance to
the test and comply with the instructions. As in Fatima's
story, the involvement of a family member in cases of
patients who do not have much say regarding their own
treatment (e.g. young people, women), may help to
reduce delays. There is also a need for innovative strate-
gies to reach out to those patients who do not initiate
treatment despite being enrolled in the programme
because of other priorities. Counselling that takes local
social and cultural context (e.g. gender dynamics, reli-
gious proscriptions) might prove useful in reducing treat-
ment delays for patients like Aslam and Saraswati.
Conclusion
The success of public health programmes is often mea-
sured through achievement of targets in terms of cover-
age, detection and cure rates. However, target-driven
success rates focus, by default, on those who access the
programme. Focusing on 'outliers' in a successful pro-
gramme, helps us to identify the unique vulnerabilities of
individuals, who respond differently to programme direc-
tives and approaches. For programme managers, a focus
on 'outliers' provides a less resource- and time-intensive
alternative to community-based studies for understand-
ing the missed opportunities for enabling comprehensive
coverage of the programme in poor urban settings.
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